There were 988 press releases posted in the last 24 hours and 210,042 in the last 365 days.
Orphazyme A/S Company announcement No. 04/2021 Company …
Company Announcement COPENHAGEN, Denmark; February 26, 2021 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions …
Press Release -Current testing follows preceding pre-clinical tests indicating efficacy of the novel PARP inhibitor stenoparib against SARS-Cov-2, the virus which is the origin of the B.1.1.7 variant, B.1.351 variant, and other variants. -Allarity …
Company announcement – No. 8 / 2021 Copenhagen, DK February 23, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, today …
Company Announcement Repurchase of up to 200,000 shares Mitigating dilution from warrant exercises and honoring commitments under our Restricted Stock Unit program Completion expected no later than June 30, 2021 COPENHAGEN, Denmark; February 23, 2021 – …
Company Announcement Copenhagen, Denmark; February 23, 2021 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2020. Below is a summary of business progress in 2020, financial performance for the year and the financial …
Orphazyme A/S Investor news No. 03/2021 …
PRESS RELEASE February 22, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, as part of its previously announced evaluation of a potential listing of its shares on the U.S. Nasdaq …
Company Announcement COPENHAGEN, Denmark; February 22, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that Tahamtan Ahmadi, M.D., Ph.D., has been appointed to the newly created position of Executive Vice President and Chief Medical Officer, Head of …
Lars Møller, who has worked with strategy execution in more than 25 countries, has joined DecideAct as a Strategy Execution Expert and partner. NEXØ, DENMARK, February 18, 2021 /EINPresswire.com/ -- Møller has run the consulting company Resultpartner …
Through ritual and remembering, they're tethered to the past; through technology and talent, they've got plenty to say about the present. DENMARK, February 16, 2021 /EINPresswire.com/ -- No mythological system has made a more powerful impression …
COPENHAGEN, Denmark, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious …
Company Announcement Submission based on positive pivotal innovaTV 204 trial results presented at the European Society of Medical Oncology Virtual Congress 2020 COPENHAGEN, Denmark and BOTHELL, Wash.; Feb 10, 2021 – Genmab A/S (Nasdaq: GMAB) and Seagen Inc …
COPENHAGEN, Denmark, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced …
ALK ends 2020 with Q4 organic growth of 16% leading to full-year revenue growth of 8% Results in line with latest guidance Growth outlook for 2021 of 8-12% in local currencies ALK’s overall strategy focus remains unchanged (Revenue growth rates are organic …
Press Release – No. 7 / 2021 Copenhagen, DK and Boston, MA, February 9, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, …
BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced Hans Schambye, the Company’s Chief Executive Officer, will participate …
Company announcement – No. 6/ 2021 Copenhagen, DK and Boston, MA, U.S., February 8, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20045078) a biotechnology company focused on the discovery, development and commercialization of innovative …
COPENHAGEN, Denmark, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (“Evaxion”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases …
Company announcement – No. 5 / 2021 Zealand Pharma to Host R&D Day on March 5, 2021 Zealand Pharma’s virtual Research & Development Day on March 5, 2021 will highlight progress across R&D pipeline and five-year strategy. Copenhagen, DK and …
Don’t miss any breaking news!
Get the EIN Presswire App
Power your mobile with the latest breaking news by country, US state or industry.
